These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15862295)

  • 1. The presence of valine at residue 129 in human prion protein accelerates amyloid formation.
    Baskakov I; Disterer P; Breydo L; Shaw M; Gill A; James W; Tahiri-Alaoui A
    FEBS Lett; 2005 May; 579(12):2589-96. PubMed ID: 15862295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt-Jakob disease.
    Tahiri-Alaoui A; Gill AC; Disterer P; James W
    J Biol Chem; 2004 Jul; 279(30):31390-7. PubMed ID: 15131108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro.
    Tahiri-Alaoui A; James W
    Protein Sci; 2005 Apr; 14(4):942-7. PubMed ID: 15741327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and structural studies of the prion protein polymorphism.
    Petchanikow C; Saborio GP; Anderes L; Frossard MJ; Olmedo MI; Soto C
    FEBS Lett; 2001 Dec; 509(3):451-6. PubMed ID: 11749972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation.
    Lewis PA; Tattum MH; Jones S; Bhelt D; Batchelor M; Clarke AR; Collinge J; Jackson GS
    J Gen Virol; 2006 Aug; 87(Pt 8):2443-2449. PubMed ID: 16847141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of N-terminal familial mutations in prion protein fibrillization and prion amyloid propagation in vitro.
    Jones EM; Surewicz K; Surewicz WK
    J Biol Chem; 2006 Mar; 281(12):8190-6. PubMed ID: 16443601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathway complexity of prion protein assembly into amyloid.
    Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
    J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
    El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
    FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.
    Vanik DL; Surewicz WK
    J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse prion protein polymorphism Phe-108/Val-189 affects the kinetics of fibril formation and the response to seeding: evidence for a two-step nucleation polymerization mechanism.
    Cortez LM; Kumar J; Renault L; Young HS; Sim VL
    J Biol Chem; 2013 Feb; 288(7):4772-81. PubMed ID: 23283973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC.
    Hosszu LL; Jackson GS; Trevitt CR; Jones S; Batchelor M; Bhelt D; Prodromidou K; Clarke AR; Waltho JP; Collinge J
    J Biol Chem; 2004 Jul; 279(27):28515-21. PubMed ID: 15123682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational pH dependence of intermediate states during oligomerization of the human prion protein.
    Gerber R; Tahiri-Alaoui A; Hore PJ; James W
    Protein Sci; 2008 Mar; 17(3):537-44. PubMed ID: 18218718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-oligomer interactions of the human prion protein are modulated by the polymorphism at codon 129.
    Gerber R; Voitchovsky K; Mitchel C; Tahiri-Alaoui A; Ryan JF; Hore PJ; James W
    J Mol Biol; 2008 Aug; 381(1):212-20. PubMed ID: 18597782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.
    Kundu B; Maiti NR; Jones EM; Surewicz KA; Vanik DL; Surewicz WK
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12069-74. PubMed ID: 14519851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
    Satheeshkumar KS; Jayakumar R
    Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation.
    Torrent J; Alvarez-Martinez MT; Harricane MC; Heitz F; Liautard JP; Balny C; Lange R
    Biochemistry; 2004 Jun; 43(22):7162-70. PubMed ID: 15170353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion Protein Prolines 102 and 105 and the Surrounding Lysine Cluster Impede Amyloid Formation.
    Kraus A; Anson KJ; Raymond LD; Martens C; Groveman BR; Dorward DW; Caughey B
    J Biol Chem; 2015 Aug; 290(35):21510-22. PubMed ID: 26175152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.
    Elmallah MI; Borgmeyer U; Betzel C; Redecke L
    Prion; 2013; 7(5):404-11. PubMed ID: 24121542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.